Bausch & Lomb

Renowned contact lens manufacturer Bausch & Lomb has been sold for US$8.7 bn to Canada's Valeant Pharmaceuticals. The sale was first mooted publicly in December 2012, with rumours of an IPO in April. Sam Anson reports and comments. more

30 May 2013 09:14 News

Oxygen transmissability to the open eye

Source: Bausch & Lomb.

Development of contact lens materials has accelerated in the last century since the advent of the original glass shell lenses. Sean Lyons of Bausch & Lomb looks at some of the latest advances. more

28 May 2013 16:15 Devices